Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1999 1
2000 1
2001 2
2002 1
2004 1
2005 1
2006 1
2007 4
2008 5
2009 1
2010 2
2011 6
2012 9
2013 4
2014 1
2015 10
2016 10
2017 13
2018 18
2019 23
2020 17
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Overview of CD24 as a new molecular marker in ovarian cancer.
Tarhriz V, Bandehpour M, Dastmalchi S, Ouladsahebmadarek E, Zarredar H, Eyvazi S. Tarhriz V, et al. Among authors: dastmalchi s. J Cell Physiol. 2019 Mar;234(3):2134-2142. doi: 10.1002/jcp.27581. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317611 Review.
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update.
Eyvazi S, Farajnia S, Dastmalchi S, Kanipour F, Zarredar H, Bandehpour M. Eyvazi S, et al. Among authors: dastmalchi s. Curr Cancer Drug Targets. 2018;18(9):857-868. doi: 10.2174/1568009618666180102102311. Curr Cancer Drug Targets. 2018. PMID: 29295696 Review.
Retraction Note: The effects of valsartan on renal glutathione peroxidase expression in alleviation of cyclosporine nephrotoxicity in rats.
Raeisi S, Ghorbanihaghjo A, Argani H, Dastmalchi S, Ghasemi B, Ghazizadeh T, Rashtchizadeh N, Mesgari Abbasi M, Bargahi N, Nemati M, Mota A, Vatankhah AM. Raeisi S, et al. Among authors: dastmalchi s. Bioimpacts. 2016;6(4):249. doi: 10.15171/bi.2016.31. Epub 2016 Dec 30. Bioimpacts. 2016. PMID: 28265540 Free PMC article.
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Ghamari N, et al. Among authors: dastmalchi s. Pharmacol Ther. 2019 Aug;200:69-84. doi: 10.1016/j.pharmthera.2019.04.007. Epub 2019 Apr 24. Pharmacol Ther. 2019. PMID: 31028835 Review.
AMPK: A promising molecular target for combating cisplatin toxicities.
Rashtchizadeh N, Argani H, Ghorbanihaghjo A, Sanajou D, Hosseini V, Dastmalchi S, Nazari Soltan Ahmad S. Rashtchizadeh N, et al. Among authors: dastmalchi s. Biochem Pharmacol. 2019 May;163:94-100. doi: 10.1016/j.bcp.2019.02.006. Epub 2019 Feb 7. Biochem Pharmacol. 2019. PMID: 30738797 Review.
Rhodopsin: structure, signal transduction and oligomerisation.
Morris MB, Dastmalchi S, Church WB. Morris MB, et al. Among authors: dastmalchi s. Int J Biochem Cell Biol. 2009 Apr;41(4):721-4. doi: 10.1016/j.biocel.2008.04.025. Epub 2008 Aug 3. Int J Biochem Cell Biol. 2009. PMID: 18692154 Review.
121 results